Does Preprocedural Age-Adjusted D-dimer Testing Have Any Advantage Before Percutaneous Pain Intervention for Detecting Potential Thrombovascular Events in Older Adults?
This retrospective study of 131 patients suggests that age-adjusted D-dimer testing is a cost-effective, non-invasive tool for identifying potential thrombovascular events in older adults (over 60) with multiple comorbidities undergoing percutaneous interventional pain procedures, particularly when values exceed 1.66 µg/mL.
Original paper licensed under CC BY 4.0 (https://creativecommons.org/licenses/by/4.0/). This is an AI-generated explanation of the paper below. It is not written or endorsed by the authors. For technical accuracy, refer to the original paper. Read full disclaimer
Every year, millions of people around the world face a silent threat: blood clots that form inside veins and travel to the lungs or heart. These events, known as venous thromboembolism, are a leading cause of illness and death, especially among older adults. As people age, their blood naturally becomes more prone to clotting, and the risk of these dangerous blockages rises sharply. Doctors often use a simple blood test to check for signs of these clots before a patient undergoes a medical procedure. This test looks for a substance called D-dimer, which is released when the body tries to break down a clot. However, because D-dimer levels naturally drift higher as people get older, a standard "pass or fail" number doesn't work well for everyone. To fix this, scientists developed an "age-adjusted" version of the test, which raises the threshold for what counts as high based on the patient's age. This adjustment helps doctors avoid unnecessary worry and testing in healthy older adults while still catching real dangers.
In a recent study conducted in Turkey, researchers asked a specific question: does using this age-adjusted blood test help doctors spot hidden blood clots in older adults before they undergo pain management injections? These injections, often given in the back or neck to treat chronic pain, are common procedures, but they carry a small risk if a patient has an undetected clot. The team, led by Hüseyin Utku Yildirim and colleagues at Karadeniz Technical University and Akdeniz University, looked back at the medical records of 131 patients who were scheduled for these procedures between May 2022 and February 2023. All the patients were over 18, but the average age was 64. Before their injections, every patient had their blood tested for D-dimer and other markers. The researchers then tracked what happened to these patients, checking if they developed any signs of blood clots or other vascular problems, and they even called them six months later to see if they had survived.
The results painted a clear picture of who was at risk. The study found that higher age-adjusted D-dimer levels were strongly linked to older age and a greater number of chronic health conditions, such as heart disease or high blood pressure. Most importantly, the test showed high sensitivity in flagging patients who actually had a potential blood clot, though it had limited specificity. Every single patient in the study who was found to have a clot had an elevated D-dimer level. However, the test demonstrated only modest discriminative power overall, with an area under the curve of 0.658. Despite this, the researchers identified a specific number that seemed to work best as a warning sign: a value of 1.66 micrograms per milliliter. If an older patient's test result was above this number, it was a strong signal that something was wrong and needed further investigation. This finding suggests that for patients over 60 with multiple health issues, checking this specific blood marker could be a simple, cost-effective way to catch dangerous clots before they cause a crisis.
Interestingly, the study also looked at whether recent infections or vaccinations played a role in these blood clot risks, a concern that had been raised by some during the pandemic. The researchers compared the blood test results of patients who had been infected with the virus or received various vaccines against those who had not. They found no significant link. Whether a patient had been vaccinated, how many doses they had received, or if they had been sick with the virus previously, none of these factors changed their D-dimer levels or their risk of having a clot. This is a reassuring finding, as it suggests that the blood clot risks seen in this group were driven by age and underlying health conditions rather than by recent medical interventions.
The study concludes that this age-adjusted blood test is a useful tool for doctors, particularly for older adults with multiple health problems who are preparing for pain procedures. By using a specific cutoff value, doctors can better decide who needs a closer look before a procedure begins. While the study was limited by its relatively small size and the fact that it looked at past records rather than following patients forward in time, the connection between high D-dimer levels, age, and hidden clots was strong and consistent. The authors suggest that making this test a routine part of pre-procedure checks could improve safety, allowing doctors to treat pain effectively while ensuring that dangerous, silent clots are not missed.
Drowning in papers in your field?
Get daily digests of the most novel papers matching your research keywords — with technical summaries, in your language.